Published in Proc Natl Acad Sci U S A on June 01, 1991
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A (1992) 7.72
Human parvovirus B19. Clin Microbiol Rev (2002) 3.44
Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J Virol (1993) 1.67
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest (1992) 1.63
Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol (1992) 1.52
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol (1993) 1.45
The structure of human parvovirus B19. Proc Natl Acad Sci U S A (2004) 1.30
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system. J Virol (1993) 1.19
Serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant VP2 proteins. Clin Diagn Lab Immunol (2002) 1.16
Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation. J Virol (1999) 1.16
A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. J Virol (1991) 1.07
Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. J Virol (2006) 1.02
Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol (2007) 1.00
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
Expression of Aleutian mink disease parvovirus capsid proteins by a recombinant vaccinia virus: self-assembly of capsid proteins into particles. J Virol (1992) 0.97
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
Human bocavirus capsid structure: insights into the structural repertoire of the parvoviridae. J Virol (2010) 0.93
Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle. J Virol (1992) 0.92
Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. J Virol (1994) 0.91
Parvovirus B19 infection and bone marrow transplantation. Ann Hematol (1992) 0.89
Parvovirus particles as platforms for protein presentation. Proc Natl Acad Sci U S A (1994) 0.88
Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J Virol (1995) 0.87
Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J (2015) 0.87
Visualization of the externalized VP2 N termini of infectious human parvovirus B19. J Virol (2008) 0.86
Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol (2000) 0.86
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice. PLoS One (2013) 0.84
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus. J Virol (1999) 0.83
Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine (2011) 0.82
Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody. J Virol (2007) 0.82
Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice. PLoS One (2013) 0.81
Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario. Can J Infect Dis (1996) 0.81
Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors. Asian J Transfus Sci (2010) 0.79
Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol (2004) 0.78
Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture. J Virol (1995) 0.78
C-terminal domain of hepatitis C virus core protein is essential for secretion. World J Gastroenterol (2005) 0.75
Epidemiology of two human protoparvoviruses, bufavirus and tusavirus. Sci Rep (2016) 0.75
The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly. PLoS Pathog (2015) 0.75
Development and evaluation of capture immunoglobulin G and M hemadherence assays by using human type O erythrocytes and recombinant parvovirus B19 antigen. J Clin Microbiol (1995) 0.75
Watching one's P's and Q's: promiscuity, plasticity, and quasiequivalence in a T = 1 virus. Biophys J (1998) 0.75
Gene expression analysis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer. Oncol Lett (2014) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The autonomously replicating parvoviruses of vertebrates. Adv Virus Res (1987) 5.80
Replication of the B19 parvovirus in human bone marrow cell cultures. Science (1986) 2.75
Characterization and molecular cloning of a human parvovirus genome. Science (1984) 2.12
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol (1988) 2.00
Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood (1987) 1.75
Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol (1988) 1.62
Kinetics of assembly of a parvovirus, minute virus of mice, in synchronized rat brain cells. J Virol (1977) 1.57
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.51
Expression of minute virus of mice structural proteins in murine cell lines transformed by bovine papillomavirus-minute virus of mice plasmid chimera. J Virol (1984) 1.51
Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol (1989) 1.37
Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood (1990) 1.29
Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods (1988) 1.29
A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A (1989) 1.22
A new peptide for human parvovirus B19 antibody detection. Scand J Infect Dis (1989) 1.19
Human parvovirus B19 and pregnancy. Clin Perinatol (1988) 1.14
Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res (1990) 1.13
Persistent parvovirus B19 infections in humans. Microb Pathog (1989) 1.11
Ultrastructural studies of H-1 parvovirus replication. IV. Crystal development and structure with the temperature-sensitive mutant ts1. J Virol (1977) 1.06
B19 parvovirus replicates in erythroid leukemic cells in vitro. J Infect Dis (1989) 0.94
Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera. J Gen Virol (1989) 0.92
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. Am J Epidemiol (2001) 12.12
Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome. J Mol Biol (1982) 11.71
Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet (1993) 10.82
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res (1981) 8.23
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 4.99
A short primer for sequencing DNA cloned in the single-stranded phage vector M13mp2. Nucleic Acids Res (1980) 4.98
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med (1994) 4.86
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Distinctive sequence of human mitochondrial ribosomal RNA genes. Nature (1980) 4.30
Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (1993) 4.12
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 4.01
Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis (1994) 3.91
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature (1996) 3.79
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box. Nature (1989) 3.74
Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 3.59
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med (1982) 3.29
The functional human dihydrofolate reductase gene. J Biol Chem (1984) 3.28
Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12
Prescribing at the hospital-general practice interface. I: Hospital outpatient dispensing policies in England. BMJ (1992) 3.09
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.05
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis (1986) 3.01
Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism. Proc Natl Acad Sci U S A (1984) 2.99
Counselling in general practice. J R Coll Gen Pract (1979) 2.99
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J Cell Biol (2001) 2.98
Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol (1998) 2.98
Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem (2000) 2.97
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med (1987) 2.93
A mutant of Arabidopsis deficient in the chloroplast 16:1/18:1 desaturase. Plant Physiol (1989) 2.93
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect (2004) 2.92
Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein OmpW. J Clin Microbiol (2000) 2.92
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Anxiety, depression and PTSD in asylum-seekers: assocations with pre-migration trauma and post-migration stressors. Br J Psychiatry (1997) 2.89
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res (1994) 2.79
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet (2000) 2.75
Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol (1987) 2.74
Involvement of DNA polymerase alpha in simian virus 40 DNA replication. J Biol Chem (1978) 2.74
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest (1989) 2.71
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 2.70
Impaired development of Th2 cells in IL-13-deficient mice. Immunity (1998) 2.68
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
In vitro production of enterotoxin and hemorrhagic principle by Vibrio cholerae, NAG. Jpn J Med Sci Biol (1972) 2.66
Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science (1994) 2.65
Vibrio cholerae O139 Bengal in Bangkok. Lancet (1993) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc Natl Acad Sci U S A (1989) 2.62
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr Biol (1996) 2.50
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet (1998) 2.43
A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell (1992) 2.43
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol (1996) 2.42
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood (2000) 2.42
Two epidemics of diarrhoeal disease possibly caused by Plesiomonas shigelloides. J Hyg (Lond) (1978) 2.41
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res (2001) 2.41
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials (1998) 2.40
High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli. J Biomol NMR (1996) 2.38
Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation (2001) 2.36
Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol (1991) 2.35
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res (1978) 2.23
Serovars of Vibrio cholerae identified during 1970-1975. Jpn J Med Sci Biol (1977) 2.21
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol (2001) 2.21
Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis. J Clin Microbiol (1996) 2.21
Virulence genes in environmental strains of Vibrio cholerae. Appl Environ Microbiol (2000) 2.21
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med (1999) 2.17
Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation (1986) 2.17